Related content

Treatment of Migraine in the Early Stages of an Attack: A Prospective, Double-blind, Placebo-controlled Trial of Eletriptan

By Brandes J.   Hilliard B.   Sikes C.   Tiseo P.  

Headache Care, Vol. 1, Iss. 4, 2004-12 ,pp. : 285-288

Informa Healthcare

Access to resources Recommend Favorite

Neck pain in chronic whiplash syndrome treated with botulinum toxin. A double-blind, placebo-controlled clinical trial

By Padberg M.   Bruijn S.F.T.M.   Tavy D.L.J.  

Journal of Neurology, Vol. 254, Iss. 3, 2007-03 ,pp. : 290-295

Springer Publishing Company

Access to resources Recommend Favorite

Outcome of transcutaneous electrical nerve stimulation in chronic pain: short-term results of a double-blind, randomised, placebo-controlled trial

By Oosterhof J.   Boo T.   Oostendorp R.   Wilder-Smith O.   Crul B.  

The Journal of Headache and Pain, Vol. 7, Iss. 4, 2006-09 ,pp. : 196-205

Springer Publishing Company

Access to resources Recommend Favorite

Published and not fully published double-blind, randomised, controlled trials with oral naratriptan in the treatment of migraine: a review based on the GSK Trial Register

By Tfelt-Hansen Peer  

The Journal of Headache and Pain, Vol. 12, Iss. 4, 2011-08 ,pp. : 399-403

Springer Publishing Company

Access to resources Recommend Favorite

Treatment with sumatriptan 50 mg in the mild phase of migraine attacks in patients with infrequent attacks: a randomised, double-blind, placebo-controlled study

By Tfelt-Hansen P.   Bach F.   Daugaard D.   Tsiropoulos I.   Riddersholm B.  

The Journal of Headache and Pain, Vol. 7, Iss. 6, 2006-12 ,pp. : 389-394

Springer Publishing Company

Access to resources Recommend Favorite